Novartis Oncology
Novartis Oncology
     

Rare Diseases

Rare diseases are illnesses that affect less than one-tenth of one percent of the population, but are life-threatening or highly disabling.

Rare illnesses may cause disability and reduced quality of life; they may place a heavy economic burden on patients and their families; and may even lead to death at a very young age. But because rare diseases affect such a small number of people, there may be few medical experts available to provide the care that patients need.

The purpose of this website is to provide patients and family members with information on three rare diseases:
  • Dermatofibrosarcoma protuberans (DFSP)
  • Hypereosinophilic syndrome (HES)/ Chronic Eosinophilic Leukaemia (CEL)
  • Myelodysplastic/myeloproliferative disorders

These diseases result from alterations to a part of the body's blood plasma called growth factors, or to enzymes in the body called kinases. When these growth factors or kinases are altered, or mutated, they send out signals, or instructions, for cells in the body to grow abnormally, causing tumors or other problems.

Click on any of the options on this page for useful information about the disorder, current treatment options, and helpful resources. You will also find information about clinical studies of new treatments for the disorder and ways to decide if being part of one of the studies is right for you.

  Print This Page



Disclaimer: This is an international website dedicated to rare diseases, and intended for patients outside the US. The information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
About Rare Diseases  |  DFSP  |  HES / CEL  |  Myelodysplastic / Myeloproliferative Diseases  |  Resources
Contact  |  Sitemap  |  Privacy
Use of this website is subject to our Terms of Use
© Novartis AG